Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionConnor, Clark & Lunn Investment Management Ltd.
Latest Disclosed Ownership67,301 shares
Latest Disclosed Value $ 153,446
Connor, Clark & Lunn Investment Management Ltd. reports 405.19% increase in ownership of 9EH / Evolent Health, Inc.

On May 11, 2026 - Connor, Clark & Lunn Investment Management Ltd. filed a 13F-HR form disclosing ownership of 67,301 shares of Evolent Health, Inc. (DE:9EH) valued at $127,199 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 13,322 shares of Evolent Health, Inc.. This represents a change in shares of 405.19% during the quarter. The current value of the position is $227,477 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F EVOLENT HEALTH CL A 30050B101 67,301 53,979 405.19 153 188.68 0.0004
2026-02-10 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 13,322 13,322 53 0.0001
2025-11-13 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 0 -403,677 -100.00 0 -100.00
2025-08-07 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 403,677 178,307 79.12 4,545 112.98 0.0160
2025-05-12 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 225,370 154,753 219.14 2,134 168.77 0.0093
2025-02-10 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 70,617 70,617 794 0.0036
2023-02-10 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 0 -24,165 -100.00 0 -100.00
2022-11-10 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 24,165 24,165 868 0.0057
2016-11-15 2016-09-30 13F Evolent Health CL A 30050B101 0 -11,400 -100.00 0 -100.00
2016-08-15 2016-06-30 13F Evolent Health CL A 30050B101 11,400 11,400 219 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.